These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24586841)

  • 1. Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
    Ihara M; Nishino M; Taguchi A; Yamamoto Y; Hattori Y; Saito S; Takahashi Y; Tsuji M; Kasahara Y; Takata Y; Okada M
    PLoS One; 2014; 9(2):e89516. PubMed ID: 24586841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis.
    Taguchi A; Takata Y; Ihara M; Kasahara Y; Tsuji M; Nishino M; Stern D; Okada M
    Psychogeriatrics; 2013 Sep; 13(3):164-9. PubMed ID: 25707423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
    Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
    CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Wolfson C; Oremus M; Shukla V; Momoli F; Demers L; Perrault A; Moride Y
    Clin Ther; 2002 Jun; 24(6):862-86; discussion 837. PubMed ID: 12117079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
    Stryjer R; Strous RD; Bar F; Werber E; Shaked G; Buhiri Y; Kotler M; Weizman A; Rabey JM
    Clin Neuropharmacol; 2003; 26(1):12-7. PubMed ID: 12567159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
    Tai SY; Chen CH; Chien CY; Yang YH
    BMC Neurol; 2017 Feb; 17(1):40. PubMed ID: 28231822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.
    Müller T; Welnic J; Fuchs G; Baas H; Ebersbach G; Reichmann H
    J Neural Transm Suppl; 2006; (71):27-30. PubMed ID: 17447412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia.
    Onofrj M; Thomas A; Iacono D; Luciano AL; Di Iorio A
    Clin Neuropharmacol; 2003; 26(5):239-51. PubMed ID: 14520164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study.
    Arai H; Takahashi T
    Am J Geriatr Psychiatry; 2009 Apr; 17(4):353-4. PubMed ID: 19307864
    [No Abstract]   [Full Text] [Related]  

  • 11. Donepezil for dementia due to Alzheimer's disease.
    Birks J; Harvey RJ
    Cochrane Database Syst Rev; 2006 Jan; (1):CD001190. PubMed ID: 16437430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.
    O'Brien BJ; Goeree R; Hux M; Iskedjian M; Blackhouse G; Gagnon M; Gauthier S
    J Am Geriatr Soc; 1999 May; 47(5):570-8. PubMed ID: 10323651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
    Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease.
    Paleacu D; Mazeh D; Mirecki I; Even M; Barak Y
    Clin Neuropharmacol; 2002; 25(6):313-7. PubMed ID: 12469005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil.
    Matsuda O
    Int Psychogeriatr; 2007 Apr; 19(2):241-52. PubMed ID: 17005066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.
    Ravina B; Putt M; Siderowf A; Farrar JT; Gillespie M; Crawley A; Fernandez HH; Trieschmann MM; Reichwein S; Simuni T
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):934-9. PubMed ID: 15965198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
    Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
    Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.